Understanding disease modifiers and heterogeneity in Alzheimer’s disease – UndoAD – Colombo-German Consortium
The main aim of the UndoAD consortium is to identify disease modifiers to explain the heterogeneity found in Alzheimer’s disease. This will be achieved in the framework of a BMBF-supported Consortium which will establish standardized laboratory techniques and launch a common educational platform.
Partners of UndoAD are:
Prof. Dr. med. Markus Glatzel / Dr. med. Diego Sepulveda Falla, Institut für Neuropathologie am Universitätsklinikum Hamburg-Eppendorf (https://www.uke.de/english/departments-institutes/institutes/neuropathology/research/index.html)
Prof. Dr. med. Inga Zerr, Leiterin der translationalen Demenzforschung am Deutschen Zentrum für Neurodegenerative Erkrankungen in Göttingen (TDG) (http://cjd-goettingen.de/)
The aims of UndoAD are:
- To establish a research network for data exchange and integration between the partners, including anonymized data resulted from clinical follow up, neuropathological analysis and biochemical studies of Alzheimer’s disease patients.
- To develop long-term joint laboratory facilities (GNA Brain Bank) in a work-sharing approach, involving tele neuropathological diagnosis and support by the Institute of Neuropathology at UKE.
- To develop third-party funded projects aimed to study disease heterogeneity in Alzheimer’s disease (see for instance NIH grant 1RF1NS110048-01).
- To organize an annual Summer School in order to socialize the UndoAD joint effort on an international level.
UndoAD – International Summer Schools
2019 – 2nd International Summer School of Dementia Diagnosis and Pathology Medellin, Colombia and 1st Latin-American Brain Banks Seminar – TBA
2018 – 1st International Summer School of Dementia Diagnosis and Pathology Medellin, Colombia, September 12th and 13th.
- Francisco Lopera, University of Antioquia.
- Yakeel Quiroz, Massachusetts General Hospital.
- Andrés Villegas, University of Antioquia.
- Patricia Cardona, University of Antioquia.
- Diego Sepúlveda-Falla, UKE Hamburg., Germany.
- Kenneth Kosik, University of California, Santa Barbara.
- Markus Glatzel, UKE Hamburg, Germany.
- Inga Zerr, University of Göttingen, Germany.
- Susanne Krasemann, UKE Hamburg, Germany.
- Mauricio Arcos-Burgos, University of el Rosario.
- Elena Becker Barroso, The Lancet Neurology Journal.